Mechanistic Insights into the Release of Doxorubicin from Graphene Oxide in Cancer Cells

Mechanistic Insights into the Release of Doxorubicin from Graphene Oxide in Cancer Cells

Liposomal doxorubicin (L-DOX) is a popular drug formulation for the treatment of several cancer types (e.g., recurrent ovarian cancer, metastatic breast cancer, multiple myeloma, etc.), but poor nuclear internalization has hampered its clinical applicability so far. Therefore, novel drug-delivery na...

Full description

Bibliographic Details
Main Authors: Erica Quagliarini, Riccardo Di Santo, Daniela Pozzi, Paolo Tentori, Francesco Cardarelli, Giulio Caracciolo
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Nanomaterials
Subjects:
doxorubicin
functional materials
graphene oxide
nanochemotherapeutics
Online Access:https://www.mdpi.com/2079-4991/10/8/1482

Internet

https://www.mdpi.com/2079-4991/10/8/1482

Similar Items